INCREASED HEPATIC SECRETION OF VERY-LOW-DENSITY-LIPOPROTEIN APOLIPOPROTEIN B-100 IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - A STABLE-ISOTOPE STUDY

We have measured the hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 (VLDL apo B) in 6 patients with heterozygous fam ilial hypercholesterolaemia (FH) (4 males, 2 females, age 47.0 +/- 2.7 years (mean +/- S.E.M.), weight 71.0 +/- 5.3 kg) and 6 normocholester olaemic subjects matched for age, weight and sex (4 males, 2 females, age 47.5 +/- 3.1 years, weight 70.0 +/- 4.4 kg) using a stable isotope method. Each subject received a primed, constant infusion of [1-C-13] leucine and isotopic enrichment of VLDL apo B was determined using gas -chromatography mass-spectrometry (GCMS), Mean plasma low-density-lipo protein (LDL) cholesterol and apo B concentrations in the FH group wer e more than twice that in the control group (FH, 8.5 +/- 0.5 mmol/l vs . controls, 3.3 +/- 0.2 mmol/l, P < 0.001; and FH, 2.0 +/- 0.1 g/l vs. controls, 1.0 +/- 0.04 g/l, P < 0.0001, respectively). Plasma triglyc eride (TC) and high-density-lipoprotein (HDL) cholesterol concentratio ns were not significantly different between the two groups. Although t he fractional secretion rates of VLDL apo B were similar (FH, 14.3 +/- 3.6 pools/day vs. controls, 11.6 +/- 1.7 pools/day, P = 0.53), VLDL a po B pool size and VLDL apo B absolute secretion rates (ASR) were sign ificantly higher in the FH group (FH, 234.2 +/- 27.8 mg vs, controls, 66.3 +/- 13.5 mg, P < 0.001; and FH, 51.4 +/- 17.9 mg/kg per day vs. c ontrols, 9.4 +/- 1.1 mg/kg per day, P < 0.02, respectively). We conclu de that FH is associated with increased hepatic secretion of VLDL apo B and that this may contribute to the elevated concentration of LDL-ch olesterol. The findings are also consistent with the hypothesis that i n FH increased hepatic cholesterol availability (due to increased upta ke of LDL-cholesterol via the receptor-independent pathway) stimulates hepatic secretion of VLDL apo B.